Abstract:Oral delivery of insulin has the potential to revolutionize diabetes care since it is regarded as a noninvasive therapeutic approach without the side effects caused by frequent subcutaneous injection. However, the insulin delivery efficiency through oral route was still limited, likely due to the chemical, enzymatic and absorption barriers. In this study, a novel type of pH- and amylase-responsive microgels as an insulin drug carrier for oral administration was developed to improve the drug delivery efficiency. The microgels were prepared via aqueous dispersion copolymerization of acrylategrafted-carboxymethyl starch (CMS-g-AA) and 2-isobutyl-acrylic acid (iBAA). The resulting hybrid microgels with the PiBAA contents of 13.6-45.3 wt% exhibited sharp pH-sensitivity, which was revealed by the changes in particle size of the microgels and the transmittance of the microgel aqueous solution. The accelerated decomposition of the CMS-containing microgels in response to amylase was demonstrated by chromogenic reaction and morphology change. Insulin was loaded into the microgels by swelling-diffusion method, and the insulin release from the insulin-loaded microgels in vitro was found to be triggered by pH change and addition of amylase, which was highly dependent on the microgel component. Cytotoxicity assay was performed to show the good biocompatibility of the microgels. In addition, the tests of cellular uptake by Caco-2 cells and transmembrane transport through the Caco-2 cell monolayers were carried out to confirm the intestinal absorption ability of the insulin-loaded microgels. Finally, the oral administration of insulin-loaded microgels to STZ-induced diabetic rats led to a continuous decline in the fasting blood glucose level within 2 to 4 h, and the hypoglycemic effect maintained over 6 h in vivo. The relative pharmacological availability of the insulin-loaded microgels was enhanced 23-38 times compared to free-form insulin solution through oral route. Therefore, the novel starch-based microgels may have potential as an efficient platform for oral insulin delivery.

Dual Stimuli-Responsive Nanoparticle-Incorporated Hydrogels As an Oral Insulin Carrier for Intestine-Targeted Delivery and Enhanced Paracellular Permeation.

Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy

Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.

Ph- and Amylase-Responsive Carboxymethyl Starch/Poly(2-isobutyl-acrylic Acid) Hybrid Microgels As Effective Enteric Carriers for Oral Insulin Delivery

Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin

Overcoming Multiple Absorption Barrier for Insulin Oral Delivery Using Multifunctional Nanoparticles Based on Chitosan Derivatives and Hyaluronic Acid

Beneficial Properties for Insulin Absorption Using Superporous Hydrogel Containing Interpenetrating Polymer Network As Oral Delivery Vehicles

Bioinspired Zwitterionic Polyphosphoester Modified Porous Silicon Nanoparticles For Efficient Oral Insulin Delivery

Intestinal-Target and Glucose-Responsive Smart Hydrogel toward Oral Delivery System of Drug with Improved Insulin Utilization

pH-sensitive chitosan-deoxycholic acid/alginate nanoparticles for oral insulin delivery

Goblet Cell Targeting Nanoparticle Containing Drug-Loaded Micelle Cores for Oral Delivery of Insulin.

Insulin-Loaded pH-Sensitive Hyaluronic Acid Nanoparticles Enhance Transcellular Delivery

pH-Responsive and Mucoadhesive Nanoparticles for Enhanced Oral Insulin Delivery: The Effect of Hyaluronic Acid with Different Molecular Weights

HP55-coated Capsule Containing PLGA/RS Nanoparticles for Oral Delivery of Insulin.

Enhancing Insulin Oral Absorption by Using Mucoadhesive Nanoparticles Loaded with LMWP-linked Insulin Conjugates.

Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery

pH and H2O2 dual-sensitive nanoparticles enable enhanced and safe glucose-responsive oral insulin delivery for diabetes mellitus treatment

Preparation and Characterization of Hydroxyapatite Nanoparticles Carrying Insulin and Gallic Acid for Insulin Oral Delivery.

Improved Oral Delivery of Insulin by PLGA Nanoparticles Coated with 5Β-Cholanic Acid Conjugated Glycol Chitosan

Preparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles

Ph-Sensitive O-carboxymethyl Chitosan/sodium Alginate Nanohydrogel for Enhanced Oral Delivery of Insulin.